DOCSLIB.ORG

Named Professorships 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Named Professorships 1 Named Professorships 1 E. Cowles Andrus Distinguished Professorship in Cardiology [2001]: NAMED PROFESSORSHIPS Edward K. Kasper, M.D. The creation of a Professorship in the School of Medicine indicates that a Funding provided by Miriam Andrus, in memory of her husband, E. Cowles sum of money has been added to the University endowment to generate Andrus, M.D. income which supports a professor in a particular department. C. Michael Armstrong Professorship [2000]: Gregg L. Semenza, M.D., A date in brackets indicates year the named professorship was Ph.D. established. Anthony F Leva Funding provided by Trustee C. Michael Armstrong to support medical John Jacob Abel Distinguished Service Professor of Pharmacology and research, with initial focus on stem cell research. Experimental Therapeutics [1962]: Unoccupied C. Michael and S. Anne Armstrong Professorship in Patient Safety [2014]: Funded by a bequest in the will of Mrs. Anne D. Hamilton of Columbus, Allen Kachalia, M.D., J.D. OH. Dr. Abel was the first Professor of Pharmacology (1893-1937) and a Funding provided by Trustee C. Michael Armstrong and his wife, S. Anne member of the original faculty of the School of Medicine. Armstrong, to support the director of the Armstrong Institute for Patient Martin D. Abeloff Professorship [2007]: Drew M. Pardoll, M.D., Ph.D. Safety and Quality. Funding provided by the Seraph Foundation (Henry and Linda Spires, Dr. Frances Watt Baker and Dr. Lenox D. Baker, Jr. Deanship of the School Trustees) for a professorship in the Department of Oncology for the of Medicine [1997]: Paul B. Rothman, M.D. purpose of advancing outstanding cancer research and treatment. The Dr. Frances Watt Baker and Dr. Lenox D. Baker, Jr. are 1966 graduates of Director of the Department of Oncology, Dean of the School of Medicine, the Johns Hopkins School of Medicine. Dr. Frances Baker is a pediatrician and Seraph Trustees has the discretion of appointment over current and and Dr. Lenox Baker is a cardiothoracic surgeon and a member of the future faculty to this professorship. Johns Hopkins University Board of Trustees and the Board of Johns Leonard & Madlyn Abramson Professorship in Neurodegenerative Hopkins Medicine. Diseases [2004]: Ted M. Dawson, M.D., Ph.D. Edmund F. and Virginia Ball Professorship in Ophthalmology [2005]: J. Funding provided by Abramson Family Foundation. Fernando Arevalo, M.D. AEGON Professorship in Prostate Cancer Research [2009]: Michael Funding provided by Mr. Edmund F. Ball. This gift will be used to support Carducci, M.D. research in macular degeneration and other disorders. Funding provided by AEGON. Dr. Freida Derdeyn Bambus Professorship in Ophthalmology [2005]: Hendrick P.N. Scholl, M.D., M.A. Aetna U.S. Health Care Professorship in Medical Genetics [1996]: Garry Cutting, M.D. Funding provided by Dr. Freida Derdeyn, a retired teacher who became acquainted with the work of the Wilmer Institute through a local group Funding provided by U.S. Healthcare Corporation. focusing on macular degeneration. Mohamad E. Allaf Directorship in Minimally Invasive Urology Surgery Theodore and Ingrid Baramki Professorship in Reproductive [2014]: Mohamad E. Allaf, M.D. Endocrinology [1994]: Howard A. Zacur, M.D., Ph.D. Income from the Principal will be used “for a directorship and research Funding provided by Dr. Theodore Baramki, a member of the faculty of program in minimally invasive urology… This gift is to be utilized by Dr. the Department of Gynecology and Obstetrics, and the estate of Clarice Mohamad E. Allaf at his discretion for salary support, clinical & research Reiss. This gift will be used to fund a professorship in reproductive programs or other purposes as determined solely by Dr. Mohamad E. endocrinology. Allaf.” The endowment will be held in the Brady Urological Institute in the School of Medicine. Philip Bard Directorship in the Department of Physiology [1999]: Unoccupied Elizabeth Plank Althouse Professor for Alzheimer’s Research in Psychiatry and Behavioral Sciences [2006]: Constantine Lyketsos, M.D., Established through commitments made in 1999 by Roger Greif, Philip M.H.S. Davies, Elizabeth B. O’Connor, Vernon Mountcastle, Timothy Harrison, and various donors in honor of Philip Bard, Professor of Physiology, 1933 to Funding provided for researching the cause, prevention, treatment, and 1964. cure of Alzheimer’s Disease. The Barry Family Professorship in Translational Medicine [2016]: Andelot Professor of Laryngology and Otology [1962]: David W. Eisele, Unoccupied M.D. The gift will be used to benefit the Sidney Kimmel Comprehensive Cancer This Professorship was funded by a grant from Mr. Lamont DuPont Center at Johns Hopkins as an endowed gift to be held in perpetuity for Copeland of Wilmington, DE, a grateful patient of Dr. John Bordley. The purpose of a professorship bearing the name. Andelot name was selected by Mr. Copeland. Baxley Professor of Pathology [1901]: Ralph H. Hruban, M.D. 2 Named Professorships A bequest in the will of Dr. Henry Willis Baxley (1824-1876) provided He is best known for the creation of the Blalock-Taussig operation for the funding for the first endowed chair in the School of Medicine. Dr. Baxley treatment of cyanotic congenital heart disease. was a graduate of the University of Maryland in 1859, was a southern sympathizer during the Civil War, and following the war practiced his Bloomberg-Kimmel Professorship of Cancer Immunotherapy [2018]: profession in Baltimore and later in Virginia. Suzanne Topalian, M.D. Stanhope Bayne-Jones Professorship in Medicine [1974]: David L. Inaugural recipient Professorship recognizing leadership in the Thomas, M.D. Bloomberg-Kimmel Institute of Cancer Immunotherapy. Mrs. Nannie S. Bayne-Jones provided the funding for this Professorship Bloomberg-Kimmel Professorship of Cancer Immunotherapy [2018]: in honor of her husband. Stanhope Bayne-Jones received his M.D. degree Cynthia Sears, M.D. from Johns Hopkins in 1914. As an expert in infectious diseases, he Inaugural recipient Professorship recognizing leadership in the served on the faculty of the University of Rochester and Yale Medical Bloomberg-Kimmel Institute of Cancer Immunotherapy. School, and he also served as Dean at Yale. In 1942, he was made a brigadier general in the Army Medical Corps and served in many Bloomberg-Kimmel Professorship of Cancer Immunotherapy [2018]: government posts during and following World War II. Jonathan Powell, M.D., Ph.D. The Sheldon B. Bearman, M.D. Professorship in the Russell H. Morgan Inaugural recipient Professorship recognizing leadership in the Department of Radiology and Radiological Sciences [2020]: Pamela T. Bloomberg-Kimmel Institute of Cancer Immunotherapy. Johnson, M.D., FACR Marjorie Bloomberg Tiven Professorship in Neurofibromatosis [2017]: A permanent endowment benefiting the Department of Radiology and Jaishri Blakeley, M.D. Radiological Sciences. To benefit the Department of Neurology as an endowed gift to be held in Bendann Family Professorship in Ophthalmology [2011]: Esen K. Akpek, perpetuity and which will support a professor in the Neurofibromatosis M.D. Therapeutic Acceleration Program. An endowment fund at the School of Medicine, the income from the John E. Bordley Chair in Otolaryngology/Head and Neck Surgery [1990]: principal will be used for faculty support and the endowment will be held Brady May, Ph.D. in the Wilmer Eye Institute. Funding for this Chair was provided by the McCarthy-Cooper Estate, Bendann-Iliff Professorship in Ophthalmology [1995]: Nicholas T. Iliff, patients, and residents of Dr. John E. Bordley, who was Director of the M.D. Department of Otolaryngology for 17 years (1952-1969). Established by Constance Bendann in honor of the Bendann Family Boury Professorship in Molecular Biology and Genetics [1937]: and Charles E. Iliff, III, one of the pioneers of oculoplastics, the surgical Unoccupied restoration of the function and appearance of the eye. This professorship was funded by a bequest in the will of Mr. Louis J. Dr. Bertram M. Bernheim Research Professorship in Surgery [1987]: Boury. Mr. Boury was a native of Baltimore who moved to New York Christopher Abularrage, M.D. where he became a successful grain merchant. Funding for this Professorship was provided by members of the Frederick Brancati Professorship [2012]: Jeanne M. Clarke, M.D., M.P.H. Bernheim family to honor Bertram M. Bernheim, a 1905 graduate of the Johns Hopkins School of Medicine. As a member of the faculty of The income from the principal will be used for faculty support and held in the Department of Surgery, he was responsible for pioneering research the Division of Internal Medicine in the Department of Medicine. which resulted in significant advancements in vascular surgery and blood transfusion. Breast Cancer Research Professorship in Oncology [1992]: Vered Stearns, M.D. The Berry-Brem Professorship in Neurosurgery [2017]: Mark Luciano, Funds were provided by Mr. and Mrs. Jeffrey Legum, Mrs. Naomi Legum, M.D. grateful patients and friends. To support faculty support dedicated to hydrocephalus research in the Department of Neurosurgery. Funding was provided by George and Mary Henry Brem Professorship in Neurosurgery [2014]: Henry Brem, M.D. Nell Berry who were long-time donors to the department. The income from the principal will be used for faculty support and held George E. Bigelow, Ph.D. Professorship [2014]: Eric Strain, Ph.D. in the Department of Neurosurgery. The professorship was funded by multiple donors with lead donations from Josh Fidler and Dr. and Mrs. To support clinical behavioral pharmacology research and teaching with a Irving Sherman. primary focus on elucidating the mechanisms of addictive disorders and developing treatments. The Patricia B. and William T. Bright Professorship in Mental Wellness [2018]: Unoccupied Alfred Blalock Chair in Surgery [1992]: John L. Cameron, M.D. The fund will support a master clinician and educator who is dedicated Funding for this Chair was provided by contributions from Dr. Blalock’s to patient care, teaching, and leadership in child psychiatry or geriatric residents. Dr. Alfred Blalock was Director of the Department of Surgery (1941-1964), and is credited with establishing the field of cardiac surgery.
Load more

Recommended publications
  • Cardiology in Poland — a European Perspective
    Kardiologia Polska 2014; 72, 2: 116–121; DOI: 10.5603/KP.2014.0027 ISSN 0022–9032 OKOLICZNOŚCIOWY ARTYKUŁ REDAKCYJNY / ANNIVERSARY EDITORIAL Cardiology in Poland — a European perspective Thomas F. Lüscher, Miłosz Jaguszewski Editorial Office of the European Heart Journal, Zurich Heart House, Zürich, Switzerland THE BEGINNING in the 1960s [2]. His reports were published long before later The Polish Cardiac Society (PCS) was founded in February technical developments allowed for its use in clinical practice 1954, just a few years after the initiation of the European [2]. During the 50th anniversary of the ESC, Tadeusz Cieszyński Society of Cardiology (ESC) on September 2, 1950. The first represented inventors from Poland at the poster exhibition. president of the PCS was between 1954 and 1961 Jerzy On November 5, 1985, Zbigniew Religa (1938–2009) Jakubowski (Fig. 1A), although before hand a Working Group (Fig. 1D) performed the first successful heart transplantation of Cardiology of the Polish Society of Internal Medicine existed at the Silesian Center for Heart Diseases in Zabrze. He was with Mściwój Semerau-Siemianowski, president (Fig. 1B). a prominent cardiac surgeon, scientist and politician. In 1964, Mściwój Semerau-Siemianowski together with Izabela he had completed his medical studies. After graduating and Krzemińska-Ławkowiczowa pioneered cardiac catheterisation military service he joined the Wolski Hospital in Warsaw where in Poland as early as 1948. Since 1954 Jerzy Jakubowski, was he trained in surgery. In the 70s he held internships in the field followed by 14 other eminent Polish cardiologists as presidents of vascular surgery and cardiac surgery in the Mercy Hospital in of the PCS (Table 1).
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • JOHNS HOPKINS UNIVERSITY ORAL HISTORY PROGRAM Myron
    JOHNS HOPKINS UNIVERSITY ORAL HISTORY PROGRAM Myron Weisfeldt Interviewed by Jennifer Kinniff September 24, 2015 Johns Hopkins University Oral History Program Interviewee: Myron Weisfeldt Interviewer: Jennifer Kinniff Subject: Life of Myron Weisfeldt Date: September 24, 2015 JK: Today is September 24, 2015. This is Jenny Kinniff, Program Manager of Hopkins Retrospective. I'm here today with Dr. Myron Weisfeldt, Johns Hopkins alumnus and professor, physician, and administrator of Johns Hopkins Medicine. Thank you for being here today. MW: It's a pleasure. JK: Could we start by talking about your family and your early life? MW: Sure. I was born in Milwaukee, Wisconsin. My father was a primary care physician, a real doctor. Not like me. My mother was a school teacher. During medical school, I married Linda, my wife, who is also a school teacher. I can assure you she had a big contribution and she used her professional teaching skills to keep me in line from time to time. I have three daughters, who are also doing well and supportive. One of them is actually in the video business. She produces for CNN in Denver and is in the media. We enjoy biking and being on the Eastern Shore, and I even enjoy skiing even now. JK: What was it like – your education in Milwaukee – when did your interest in medicine develop? MW: I sort of floated into it. My father was very vigorous and active. He delivered babies, set fractures and took care of heart attacks. And I got interested in heart attacks and why people died, even in high school.
    [Show full text]
  • Implantable Cardioverter Defibrillators
    CME Cardiology Implantable an MI and heart failure with significant left ventricular systolic dysfunction con- tinue to have a high rate of SCD. cardioverter The first implantable cardioverter defibrillator (ICD) to manage SCD was defibrillators implanted in a human by Michel Mirowski in 1980 (Fig 1). Since then there has been an explosion in technology and Stuart Harris BSc(Hons) MBBS MRCP(UK), randomised control trial data to support Consultant Cardiologist, Essex Cardiothoracic their use. Centre, Basildon and Thurrock University Hospitals NHS Foundation Trust Mehul Dhinoja BSc(Hons) MBBS MRCP(UK), What are the components of an Specialist Registrar in Cardiology, The Heart implantable cardioverter Hospital, University College London Hospitals defibrillator? NHS Foundation Trust An ICD comprises: Clin Med 2007;7:397–400 • a lithium silver vanadium oxide Fig 1. Michel Mirowski MD (1924–90). battery, which provides low voltage energy patients with symptomatic heart failure Who needs an implantable a transformer which multiplies this • and dyssynchrony of ventricular contrac- cardioverter defibrillator? voltage tion a further lead can be placed in the In the UK, sudden cardiac death (SCD) • an aluminium electrolytic capacitor lateral tributaries of the coronary sinus occurs in 70,000–100,000 patients annu- which can store the high energy for cardiac resynchronisation (Fig 2). ally, mainly caused by ventricular voltage for use, and The basic detection of ventricular arrhythmias. Most of these patients have • sensing circuitry which can sense arrhythmias involves measuring heart recognised heart disease with either a local electrograms and filter out rate above which therapy will be deliv- previous myocardial infarction (MI) or noise like skeletal myopotentials.
    [Show full text]
  • Poliomyelitis and the Salk Vaccine
    Poliomyelitis and the Salk Vaccine Table of Contents Preface......................................................................................................................................................................................................... 2 Center for the History of Medicine ......................................................................................................................................................... 2 Introduction ................................................................................................................................................................................................. 3 Collections .................................................................................................................................................................................................. 5 1 Return to Table of Contents Preface The Bentley Historical Library and the Historical Center for the Health Sciences (now the Center for the History of Medicine), with support from the Southeast Michigan Chapter of the March of Dimes Birth Defects Foundation, collaborated to commemorate the 40th anniversary of the announcement that the poliomyelitis vaccine developed by Dr. Jonas Salk was safe and effective. As part of the commemoration, a printed guide was prepared to highlight and illustrate the archival and manuscript holdings in the Bentley Historical Library relating to polio and the development and the testing of the Salk vaccine. In the period since the guide was published,
    [Show full text]
  • 17 Stern.P65
    Folia Cardiol. 2006, Vol. 13, No. 5, pp. 439–440 Copyright © 2006 Via Medica PEARLS AND GIANTS IN CARDIOLOGY ISSN 1507–4145 “He that was dreaming… Saw his dream through” [Didi Manoussi, popular Israeli songwriter] Michel Mirowski (1924–1990) Frequently important innovations in diologist, he needs top overseas training. medicine, and not only just in medicine, are Upon receiving a fellowship, Michel ini- the consequence of circumstances. No one tially worked at the Instituto de Cardiolo- will belittle Alexander Fleming’s contribu- gica in Mexico City under Enrique Cabre- tion to the discovery of the miraculous ef- ra and Sodi-Pallares then he transferred fects of penicillin because his breakthrough to Baltimore, Maryland as a fellow of observation was realized when he stum- Dr. Helen Taussig’s department. Only in bled upon mold falling from the roof of his 1963, after this extensive post-graduate laboratory which inhibited the growths of training, did he return to Israel with his Staphylococcus aureus. On the other hand, wife and three children. other inventors carefully plan and diligently pursue In Israel Michel’s professional life was not wi- an idea or a concept and Michel Mirowski, whose life thout obstacles. His desire to work as a senior and achievements will be described here, belongs to member at the large and prestigious Tel Hashomer this category of geniuses. Michel had a dream and Hospital’s cardiology department, did not materia- he spent years of labor struggling to see it through. lize. Despite this set back he became a respected Mieczyslaw Friedman was born in 1924 in member of Tel Hashomer’s Department of Medi- Warsaw, Poland to a Jewish family and his family cine and here started his life-long admiration of Prof.
    [Show full text]
  • Families, Patients, and Health Care During Manitoba's Polio Era, 1928
    ‘It has impacted our lives in great measure’: Families, Patients, and Health Care during Manitoba’s Polio Era, 1928 – 1953 By Leah Morton A thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of Doctor of Philosophy Department of History University of Manitoba Winnipeg Manitoba Copyright © 2013 by Leah Morton Abstract This dissertation examines the broad social impacts of the multiple polio epidemics that occurred in Manitoba between 1928 and 1953, a period I refer to as the epidemic era. It argues that examining the six major polio epidemics as an era, and the disabilities it engendered are useful windows into twentieth-century social history, particularly in terms of the capacities and limits of the state to control and manage disease, illness, and health, and the myriad ways the family negotiated discourses about disability and the intersections of disability and gender. It also examines the changes to nurses’ labour during the epidemic era, particularly in terms of the introduction of two new technologies of care – respirators and the Kenny method – both of which led to nursing shortages in the later epidemic, exposing the lingering gendered conceptions about women and voluntary nursing. This project also considers the post-war development of rehabilitation programs, and argues that they worked to discursively transform people with an illness into people with disabilities, in need of reformation in order to become useful, contributing citizens. Finally, this dissertation examines the impact of polio-related disabilities on the lived experiences of a number of Manitobans, and argues that while polio and ideologies about disability worked to shape their lives in many ways, these were not the only forces to impact people’s lives and that people with polio-related disabilities negotiated the quotidian aspects of life much like anyone else.
    [Show full text]
  • Download Issue
    HopkinsNEWS FOR FRIENDS OF THE JOHNS HOPKINS HEARTPulse AND VASCULAR INSTITUTE FALL 2018 Rooted in Philanthropy, ARVD/C Program Thrives 20 Years Later hen John Campanella was diagnosed with early symptoms of arrhythmogenic right ventricular Wdysplasia/cardiomyopathy (ARVD/C) at Johns Hopkins 20 years ago, the only hospitals John and Kathy Campanella with specialized ARVD/C centers were in Padua, garnered funding to launch the Italy, and in Arizona. Campanella was concerned Johns Hopkins ARVD/C Program. because his father, a former linebacker and general manager for the Baltimore Colts, died of the condition (then thought to be a heart attack) in Thanks to such support, electrophysiologist family.” his mid-30s. His sister Carrie, also an athlete, died Hugh Calkins opened the Johns Hopkins The Johns Hopkins ARVD/C program, which suddenly of the condition after riding a horse. She, ARVD/C program for research and treatment of has become the biggest of its kind in the world, too, was in her mid-30s. the rare, inherited heart muscle condition that can will celebrate its 20th anniversary in May 2019. The Campanella and his wife, Kathy, visited both cause sudden death in young athletes. Calkins program has evaluated more than 2,500 patients from ARVD/C centers and proposed that Johns Hopkins hired cardiology fellow Hari Tandri and a genetic all over the world and provides information through establish a program in Baltimore. The Campanellas counselor, while Kathy Campanella linked the its website, newsletters, annual reports, an annual leveraged family funds and contacted investor Jack program to a patient support website she had started, patient and family conference, and via Feeling the Bogle, an ARVD/C patient who founded and served arvd.com.
    [Show full text]
  • BCMJ -#52Vol5-June-2010-Tara
    Marc W. Deyell, MD, FRCPC, Stanley Tung, MD, FRCPC, Andrew Ignaszewski, MD, FRCPC The implantable cardioverter- defibrillator: From Mirowski to its current use Sudden cardiac death can be prevented in two broad categories of patients—those who have survived a life-threatening ventricular arrhythmia or who have sustained ventricular tachycardia, and those who have not experienced sudden cardiac arrest but are known to be at increased risk. ABSTRACT: Sudden cardiac death y the mid-20th century it Michel Mirowski is the initial presentation for many was well known that ven- Mieczyslaw (Michel) Mirowski was patients with cardiac disease. Dr tricular arrhythmias were born 14 October 1924 in Warsaw, Michel Mirowski was a pioneering Bthe mechanism of death in a Poland.4 The story of his early life is cardiologist who recognized the large proportion of patients with car- nothing short of incredible. He grew public health importance of this diac disease. The 1960s brought with up in a middle-class family among the fact. In the 1970s his efforts led to them the advent of electronic moni- large Jewish population of Warsaw at the development of the implantable toring, cardiopulmonary resuscita- that time, but his relatively comfort- cardioverter-defibrillator that has tion, and synchronized cardiover- able life changed dramatically with revolutionized the ability to prevent sion.1-3 Once clinicians had tools at the outbreak of the Second World War. and treat sudden cardiac arrest. their disposal for the treatment of ven- With the invasion of Poland by the However, in the first decade of the tricular arrhythmias, it was not sur- Nazis in 1939, Michel knew he could 2000s these devices remain under- prising to see the first coronary care not stay in Poland, but he was deter- utilized in British Columbia and units opened in 1962.2 mined to continue his education.
    [Show full text]
  • Of Anatomy Scharrerfrederick A
    Oliver S. Strong Robert R. Bensley W. Henry Hollinshead CarmineJohn D. Clemente E. Pauly Elizabeth C. Crosby Richard L. Drake G. Carl Huber Ross G. Harrison Oliver S. Strong Wendell J.S. KriegHenry J. Ralston, III Thomas Hunt Morgan Murray L. Barr Charles Judson Herrick Charles WilliamP. Leblond D. WillisDuane E. Haines George Emil Palade Florence R. Sabin Rita Levi-Montalcini John E. Pauly Charles P. Leblond Mettler Leslie Brainerd Arey StephenClement W. Ranson A. Fox Robert D. Yates Elizabeth Dexter HayJ.C. BoileauMurrayDavid Grant L. BarrBodianClement A. Fox Olof LarsellCharles P. Leblond Elizabeth Dexter Hay Charles Judson HerrickRussell T. WoodburneHarland Winfield Mossman George Emil Palade Raymond C. Truex Duane E. Haines Charles P.Rita Leblond Levi-MontalciniThomas Hunt Morgan Edward Anthony Spitzka Bradley M. Patten Malcolm B. Carpenter Florence R. Sabin Frederick A. Alan Peters Charles E. Slonecker Clement A. Fox Barry Joseph Anson the Robert D. Yates SanfordElizabeth C. L.Crosby Palay Aaron J. Ladman Clement A. Fox Aaron J. Ladman Don Wayne FawcettHenry J. Ralston, III Wendell J.S. Krieg Sanfordmany L. Palay Edward AnthonyOliver Spitzka S. Strong Raymond C. Truex Charles E. Slonecker John V. BasmajianLouis B. FlexnerCharles Mayo GossRussell T. Woodburne William D. Willis Robert R. BensleyLouis B. Flexner Leslie Brainerd Arey Jan Langman Carmine D. ClementeFrederickErnst A. Mettler Scharrer Aaron J. Ladman Aaron J. LadmanCharles Judson Herrick Edward AllenCharles Boyden Mayo Goss Keith R. Porter Frederick A. Mettler Keith L. Moore Berta V. Scharrer Bradley M.Faces Patten Oscar V. Batson Thomas Hunt Morgan Carmine D. ClementeErnstof Anatomy ScharrerFrederick A. Mettler Charles Judson Herrick William D.
    [Show full text]
  • Risk Stratification and Role of Implantable Defibrillators for Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy Barry J
    Circulation Journal REVIEW Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Risk Stratification and Role of Implantable Defibrillators for Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy Barry J. Maron, MD Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young peo- ple, including trained athletes. It is now 30 years since the introduction of implantable cardioverter-defibrillators (ICDs) to clinical cardiovascular practice and coronary artery disease, and now device therapy represents the most significant therapeutic innovation and the only definitive strategy for prolonging the life of HCM patients. ICDs have proved effective in preventing SCD in young HCM patients with appropriate intervention rates of 11% for secondary and 4% for primary prevention, despite massive left ventricular (LV) hypertrophy, LV outflow obstruc- tion, diastolic dysfunction or microvascular ischemia. Targeting candidates for prophylactic ICD therapy can be complex, compounded by the unpredictability of the arrhythmogenic substrate, the absence of a dominant risk factor, and difficulty in assembling randomized trials. However, a single major risk factor is often sufficient to justify an ICD, although additional markers and other disease features can resolve ambiguous decision-making. Nevertheless, the absence of all risk factors does not convey absolute immunity to SCD. The current risk factor algorithm, when combined with a measure of individual physician judgment (and patient autonomy considerations), is an effective guide to identifying high-risk HCM patients. ICDs have altered the natural history of HCM for many patients and provided an opportunity to achieve many decades of productive life, and the potential for normal or near-normal longevity.
    [Show full text]
  • David Bodian 1910-1992
    DAVID BODIAN 1910-1992 A Biographical Memoir by MARK E. MOLLIVER © 2012 National Academy of Sciences Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. DAVID BODIAN May 15, 1910–September 18, 1992 BY MARK E. MOLLIVER 1 DAVID BODIAN WILL BE REMEMBERED as one of the most innovative neurosci- entists of the 20th century. Committed to science, humanity, and education, he never sought recognition or power. His demeanor was marked by gentle modesty and dedication to colleagues and students. David’s kindness and modesty are inspiring in view of his numerous contributions to biomedical science, especially his role in one of the most significant biomedical advances of the past century. Over the course of his career he made discoveries that provided the groundwork for development of the polio vaccine that has nearly eradicated poliomyelitis, one of the most feared diseases in the world. Production of the vaccine was an urgent national priority that depended on the contributions and collaboration DAVID BODIAN DAVID of many researchers, and was marked by intense competition and drama. I will being inspired by a new high school science course that included laboratories for problem solving and inquiring summarize a few highlights of Bodian’s role in the polio adventure, and refer you into the workings of nature. to a fascinating account of the polio story in the book Polio: An American Story Based on his intelligence and excellent academic (Oshinsky, 2008). performance, Bodian finished high school in three years and entered Crane Junior College.
    [Show full text]